TESTBANK-
FOCUSONNURSINGPHARMACOLOGY9THEDITI
ONBY AMYKARCHCHAPTER1-
F#
59|COMPLETEGUIDE2023
,Test Bank F#- F#Focus F#on F# Nursing F#Pharmacology F#(9th F#Edition
.F 3
F#by F#Karch)
Chapter 01 - Introduction to Drugs F# F# F# F# F#
AnurseworkingF#in F#radiologyadministersiodineF#to F#apatientwhoF#is
F#havingacomputedtomography(CT)scan.
.F
F# The nurseworking ontheoncologyunit administerschemotherapytoF#patients whohavecancer.F#At the
.F .F .F .F
F# Public F#Health F#Department,F#anurseadministersameasles-mumps-rubella (MMR) F#vaccineF#to F#a 1 4- .F .F
F# month-oldchildF#asF#aroutineimmunization.F#Which branchofpharmacologybest describesthe .F .F .F
F#actions F#ofallthreenurses?
Pharmacoeconomics
F# Pharmacotherapeuti
c
F# sPharmacodynamics
F# Pharmacokinetics
F# Ans: B
Feedback:
PharmacologyF#is F#thestudyofthebiologiceffectsofchemicals.F#Nursesareinvolved F#with F#clinical
F#pharmacologyorpharmacotherapeutics,F#whichF#isF#a branchofpharmacologythatdealswiththeuses
.F .F
F # ofdrugsto F#treat, F#prevent, F#and F#diagnosedisease. F#Theradiologynurseis F#administeringadrug F#to
.F
F#helpdiagnose F#a disease.F#TheoncologynurseisadministeringF#a drug toF#helptreatadisease.
.F .F .F .F
Pharmacoeconomicsincludesanycosts involved inF#drugtherapy.F#Pharmacodynamicsinvolveshow
.F .F
F#adrug F#affectsthebodyandF#pharmacokineticsisF#how F#thebodyactsonthebody.
.F
Aphysicianhasorderedintramuscular(IM) F#injectionsofmorphine,F#a narcotic,F#every4 F#hoursasneededF#forpain
.F .F
F#ina motorvehicleaccident victim.ThenurseisawareF#thisdrughasahighF#abusepotential.
.F .F .F .F
Underwhatcategorywouldmorphinebeclassified?
.F
ScheduleF#I
F# ScheduleF#II
F# Schedule
F# IIISchedule
.F
F# IVF#Ans: B
Feedback:
Want F#toearn $1.236
.F
Distribution F#of F#this F#document F#is extra per F#year?
.F
F#illegal
,Test Bank F#- F#Focus F#on F# Nursing F#Pharmacology F#(9th F#Edition
.F 4
F#by F#Karch)
NarcoticswithahighabusepotentialareclassifiedasScheduleIIdrugsbecauseofseveredependence
.F .F .F
Want F#toearn $1.236
.F
Distribution F#of F#this F#document F#is extra per F#year?
.F
F#illegal
, Test Bank F#- F#Focus F#on F# Nursing F#Pharmacology F#(9th F#Edition
.F 5
F#by F#Karch)
liability. F#Schedule F#I drugs F#havehigh F#abusepotential F#and F#no F#acceptedmedicaluse. F#Schedule F#III
.F
F#drugshave F#a F#lesser F#abuse F#potential F#than F#II F#and F#an F#accepted F#medical F#use. F#Schedule F#IV
F#drugs F#have F#low F#abusepotential F#and limitedF#dependenceliability. .F
When involvedF#in F#phase F#IIIdrugevaluation F#studies, F#whatresponsibilitieswould the nurse
.F .F .F .F
F# have?Workingwith animalsF#whoare givenexperimentaldrugs
.F .F
ChoosingappropriatepatientsF#toF#beinvolvedF#in the F#drugstudy .F
F# MonitoringF#andF#observingpatientscloselyforadverseeffects
F# ConductingresearchtodetermineeffectivenessofthedrugAns:
.F .F .F
F # C
Feedback:
PhaseF#III studiesinvolveF#useofadrugF#in a F#vastclinicalpopulation F#in F#whichpatientsareaskedF#to
.F .F
F#recordany F#symptomstheyexperiencewhiletakingthedrugs.F#Nursesmayberesponsibleforhelpingcollect
F#and analyze F # theinformation F#to F#be sharedwiththe F#Food F#and F#Drug F#Administration(FDA)
.F .F
F#butwouldnotconductresearch F# independentlybecausenursesdonotprescribemedications. F#Useofanimals
.F
F#inF#drugtestingisdoneF#in the F# preclinicaltrials.F#Selectpatientswhoare involvedin F#phase F#IIstudies F#to
.F .F
F#participatein F#studieswherethe F#participantshavethediseasethedrugF#is intendedF#to F#treat. .F
F#Thesepatientsaremonitoredcloselyfordrugaction F#and adverseF#effects.F#Phase .F
F#I studiesinvolvehealthyhumanvolunteerswhoF#areusuallypaidfortheir
.F .F
F#participation.Nursesmayobserveforadverseeffectsandtoxicity.
What conceptF#isconsideredwhenF#genericdrugsaresubstitutedforbrandname
.F .F .F
F# drugs?Bioavailability
Critical
F#concentrationDistrib
F# ution
Half-life
F# Ans: A
Feedback:
Bioavailabilityistheportionofa doseofadrugF#thatreachesthesystemiccirculationandF#isavailabletoF#actF#on
.F .F .F .F
F#bodycells. F#BindersusedF#in F#agenericdrugmaynotbe thesameF#as thoseusedF#in F#thebrandnamedrug.
.F .F
Therefore,F#thewaythebodybreaksdownandF#usesthedrugmaydiffer,F#whichmayeliminateagenericdrug
.F
F # substitution.F#Criticalconcentration F#is F#theamountofadrugthatis F#neededto F#causeatherapeuticeffect .F
Want F#toearn $1.236
.F
Distribution F#of F#this F#document F#is extra per F#year?
.F
F#illegal
FOCUSONNURSINGPHARMACOLOGY9THEDITI
ONBY AMYKARCHCHAPTER1-
F#
59|COMPLETEGUIDE2023
,Test Bank F#- F#Focus F#on F# Nursing F#Pharmacology F#(9th F#Edition
.F 3
F#by F#Karch)
Chapter 01 - Introduction to Drugs F# F# F# F# F#
AnurseworkingF#in F#radiologyadministersiodineF#to F#apatientwhoF#is
F#havingacomputedtomography(CT)scan.
.F
F# The nurseworking ontheoncologyunit administerschemotherapytoF#patients whohavecancer.F#At the
.F .F .F .F
F# Public F#Health F#Department,F#anurseadministersameasles-mumps-rubella (MMR) F#vaccineF#to F#a 1 4- .F .F
F# month-oldchildF#asF#aroutineimmunization.F#Which branchofpharmacologybest describesthe .F .F .F
F#actions F#ofallthreenurses?
Pharmacoeconomics
F# Pharmacotherapeuti
c
F# sPharmacodynamics
F# Pharmacokinetics
F# Ans: B
Feedback:
PharmacologyF#is F#thestudyofthebiologiceffectsofchemicals.F#Nursesareinvolved F#with F#clinical
F#pharmacologyorpharmacotherapeutics,F#whichF#isF#a branchofpharmacologythatdealswiththeuses
.F .F
F # ofdrugsto F#treat, F#prevent, F#and F#diagnosedisease. F#Theradiologynurseis F#administeringadrug F#to
.F
F#helpdiagnose F#a disease.F#TheoncologynurseisadministeringF#a drug toF#helptreatadisease.
.F .F .F .F
Pharmacoeconomicsincludesanycosts involved inF#drugtherapy.F#Pharmacodynamicsinvolveshow
.F .F
F#adrug F#affectsthebodyandF#pharmacokineticsisF#how F#thebodyactsonthebody.
.F
Aphysicianhasorderedintramuscular(IM) F#injectionsofmorphine,F#a narcotic,F#every4 F#hoursasneededF#forpain
.F .F
F#ina motorvehicleaccident victim.ThenurseisawareF#thisdrughasahighF#abusepotential.
.F .F .F .F
Underwhatcategorywouldmorphinebeclassified?
.F
ScheduleF#I
F# ScheduleF#II
F# Schedule
F# IIISchedule
.F
F# IVF#Ans: B
Feedback:
Want F#toearn $1.236
.F
Distribution F#of F#this F#document F#is extra per F#year?
.F
F#illegal
,Test Bank F#- F#Focus F#on F# Nursing F#Pharmacology F#(9th F#Edition
.F 4
F#by F#Karch)
NarcoticswithahighabusepotentialareclassifiedasScheduleIIdrugsbecauseofseveredependence
.F .F .F
Want F#toearn $1.236
.F
Distribution F#of F#this F#document F#is extra per F#year?
.F
F#illegal
, Test Bank F#- F#Focus F#on F# Nursing F#Pharmacology F#(9th F#Edition
.F 5
F#by F#Karch)
liability. F#Schedule F#I drugs F#havehigh F#abusepotential F#and F#no F#acceptedmedicaluse. F#Schedule F#III
.F
F#drugshave F#a F#lesser F#abuse F#potential F#than F#II F#and F#an F#accepted F#medical F#use. F#Schedule F#IV
F#drugs F#have F#low F#abusepotential F#and limitedF#dependenceliability. .F
When involvedF#in F#phase F#IIIdrugevaluation F#studies, F#whatresponsibilitieswould the nurse
.F .F .F .F
F# have?Workingwith animalsF#whoare givenexperimentaldrugs
.F .F
ChoosingappropriatepatientsF#toF#beinvolvedF#in the F#drugstudy .F
F# MonitoringF#andF#observingpatientscloselyforadverseeffects
F# ConductingresearchtodetermineeffectivenessofthedrugAns:
.F .F .F
F # C
Feedback:
PhaseF#III studiesinvolveF#useofadrugF#in a F#vastclinicalpopulation F#in F#whichpatientsareaskedF#to
.F .F
F#recordany F#symptomstheyexperiencewhiletakingthedrugs.F#Nursesmayberesponsibleforhelpingcollect
F#and analyze F # theinformation F#to F#be sharedwiththe F#Food F#and F#Drug F#Administration(FDA)
.F .F
F#butwouldnotconductresearch F# independentlybecausenursesdonotprescribemedications. F#Useofanimals
.F
F#inF#drugtestingisdoneF#in the F# preclinicaltrials.F#Selectpatientswhoare involvedin F#phase F#IIstudies F#to
.F .F
F#participatein F#studieswherethe F#participantshavethediseasethedrugF#is intendedF#to F#treat. .F
F#Thesepatientsaremonitoredcloselyfordrugaction F#and adverseF#effects.F#Phase .F
F#I studiesinvolvehealthyhumanvolunteerswhoF#areusuallypaidfortheir
.F .F
F#participation.Nursesmayobserveforadverseeffectsandtoxicity.
What conceptF#isconsideredwhenF#genericdrugsaresubstitutedforbrandname
.F .F .F
F# drugs?Bioavailability
Critical
F#concentrationDistrib
F# ution
Half-life
F# Ans: A
Feedback:
Bioavailabilityistheportionofa doseofadrugF#thatreachesthesystemiccirculationandF#isavailabletoF#actF#on
.F .F .F .F
F#bodycells. F#BindersusedF#in F#agenericdrugmaynotbe thesameF#as thoseusedF#in F#thebrandnamedrug.
.F .F
Therefore,F#thewaythebodybreaksdownandF#usesthedrugmaydiffer,F#whichmayeliminateagenericdrug
.F
F # substitution.F#Criticalconcentration F#is F#theamountofadrugthatis F#neededto F#causeatherapeuticeffect .F
Want F#toearn $1.236
.F
Distribution F#of F#this F#document F#is extra per F#year?
.F
F#illegal
